Dr. Marc-André Gagnon at the Foreign Affairs and International Development Committee

On May 9th, 2022. See this statement in context.

May 9th, 2022 / 12:10 p.m.

Associate Professor, School of Public Policy and Administration, Carleton University, As an Individual

Okay.

I had finished talking about AstraZeneca and was talking about the Canadian firm Genevant, which owns many of the patents for messenger RNA vaccines. Providence Therapeutics, an Alberta company which wanted to work on messenger RNA technology transfers for vaccines, was interfered with systematically. It was impossible to go forward.

Biolyse Pharma wasn't the only company that could produce vaccines. PnuVax, next door to the National research Council of Canada in Montreal, could produce some. Canada's Providence Therapeutics could handle the technology transfer, but was institutionally prevented from doing so.

See context to find out what was said next.